Postoperative complications of arm ports – Full Text

“Currently, investigations specifically predicting the risk of arm port-related complications in gynecological oncology patients are limited. The advances of precision medicine warrant the development of individualized risk prediction tools to optimize clinical decision-making” Su et al (2026).
PICC-port complications in breast cancer patients

“Breast cancer patients experienced significantly fewer PICC-port complications and demonstrated excellent device survival. These findings suggest that PICC-ports may be a particularly suitable first-line vascular access option for selected patients with breast cancer” Beaufrère et al (2026).
Residual deposits in implanted intravenous ports – Full Text

“These findings suggest a link between flow dynamics and deposit accumulation, indicating that revisions to nursing guidelines-including standardized insertion, increased flushing volumes, and simulation-based competency training-may help support improved port function and potentially lower complication risks” Fu et al (2026).
Preoperative venography prior to port implantation – Full Text

“Given the limitations of ultrasound-guided totally implantable venous access ports (TIVAPs) placement in detecting venous abnormalities and predicting pinch-off syndrome, this study evaluates whether preoperative venography can improve surgical planning and reduce complications by identifying these anatomical risks prior to implantation” Yan et al (2026).
Implantable port tip positioning in adult cancer patients

“These findings support ultrasound-guided SVC-RAJ positioning as a clinically relevant strategy for reducing CRT risk and maintaining reliable venous access in contemporary oncology care pathways” Ling et al (2026).
Totally implantable venous access port review – Full Text

“This narrative review presents a review of TIVAP clinical applications and maintenance, incorporating the latest evidence-based strategies for implantation and complication mitigation” Yu et al (2026).
Landmark-based implantable port placement in a low-resource setting – Full Text

“Totally implantable venous access port (TIVAP) placement is routinely recommended under ultrasound guidance to reduce complications. However, in low-resource settings, the anatomical landmark technique remains widely used” Yavuz et al (2026).
Upper arm PICC-port placement in breast cancer patients – Full Text

“This study describes our experience in managing three breast cancer patients with PLSVC and proposes a safe and efficient approach for port placement” Gao et al (2026).
Implanted port flush frequency

“Findings suggest that prolonged intervals between flushes may increase risks associated with stagnant IVAP contents. This research highlights the need for further studies to establish safe and evidence-based flush frequencies” Sarver et al (2026).
Totally implantable catheter position in female patients – Full Text

“This study aimed to evaluate the change in the position of totally implantable venous access devices in patients with mammary hypertrophy compared to patients without this condition, in both supine and upright positions” Portugal et al (2026).
Implantable port devices for Duchenne Muscular Dystrophy patients

“Newly approved intravenous therapies for Duchenne muscular dystrophy (DMD) have led to unique challenges. Totally implantable venous access ports can be utilized to provide stable intravascular access but can be associated with procedural complications and long-term issues” Batley et al (2026).
Nurse-driven implantable port access CLABSI reduction algorithm

“Following increased port-related central line–associated bloodstream infections (CLABSIs), a clinical nurse specialist–led team developed a nurse-driven algorithm for port access” Miller and Hart (2026).
Implantable port catheter tip position – Full Text

“Totally implantable venous access ports (TIVAP) provide safe and com-fortable venous access for chemotherapy. This study evaluates the reliability of Lum’s measurement technique for central venous catheter tip positioning and its impact on complications” Akpolat et al (2026).
Fluoroscopy-free ultrasound-guided port implantation

“Fluoroscopy-free port implantation using US-guidance combined with height-based catheter length estimation demonstrated high technical success and acceptable complication rates in this large retrospective cohort” Bayrak et al (2027).
Predicting unplanned removal of totally implantable venous access ports – full Text

“This study developed a machine learning prediction model for the risk of unplanned removal of totally implantable venous access ports (TIVAP) in breast cancer patients” Wang et al (2026).
Implantable ports for intravenous access in electroconvulsive therapy

“There was a low rate of serious complications, and no fatalities were associated with having a port. We conclude that the use of ports is a safe and important option for IV access, especially in patients receiving maintenance ECT” Entenman and Maixner (2026).
Implantable port tunneling technique

“No statistically significant differences were observed in pain scores, patient satisfaction, procedure duration, or complication rates between the two approaches. These findings suggest that omitting tunnel-site anesthesia may be feasible when a blunt-tip stylet is employed” Bolgen and Karluka (2026).
Totally implanted vascular access devices-related infections

“The aim of this study was to retrospectively analyze the incidence and etiology of infections in patients with TIVAD, with a distinction between oncology and hematology patients” Misterka et al (2026).
Implantable port maintenance interval

“A 24-week TIVAP maintenance interval after completion of intravenous therapy appeared feasible and safe in this real-world cohort, with no infections and excellent port survival” Pina-Cabral et al (2026).
Totally implantable venous access device-related venous thrombosis – Full Text

“This study aimed to examine the prevalence and associated risk factors of TIVAD-related venous thrombosis in breast cancer patients undergoing chemotherapy” Li et al (2026).
Comparative study of CICC ports and PICC-ports

“This study aimed to describe and compare QoL in women with breast cancer who received a totally implantable vascular device, either a chest port (CICC port) or a peripherally inserted port (PICC-port)” Soldani et al (2026).
UEDVT PICC-port and chest port comparison – Full Text

“This meta-analysis aims to systematically evaluate the impact of left- vs. right-sided TIVAP implantation on CRT risk, providing evidence-based support for clinical prevention strategies” Fan et al (2026).
Effect of virtual reality on pain and anxiety during central venous port implantation – Full Text

“The value of music (MUS) and virtual reality (VR) in reducing pain or anxiety during central venous port implantation (CVPI) is controversial” Ghimouz et al (2026).
Implantable port insertion by interventional radiologists – Full Text

“Chemoport insertion using ultrasound-guided internal jugular access with fluoroscopic confirmation is the current preferred approach. The results from our study reinforce the safety and practicality of this type of procedure, which is simple to perform by interventional radiologists” Vargas et al (2026).
Catheter fracture following implantable port removal – Full Text

“Our goal is to discuss spontaneous catheter fracture of a central venous access port leading to a retained fragment in an adult” Clare and Turfah (2026).
Local anaesthetic for implantable port insertion – Full Text

“Alkalinizing lidocaine with epinephrine significantly reduced pain during Port-a-Cath placement in cancer patients, improving anesthesia quality and patient satisfaction” Belaid et al (2025).
Optimal implantable port catheter insertion depth – Full Text

“Non-contrast chest CT 3D reconstruction shows greater accuracy in preoperative depth prediction compared to IC-ECG. It may thus be a preferential alternative when intraoperative guidance is unavailable” Lv et al (2026).
Totally implantable port for patients with acute leukemia – Full Text

“Our study shows that TIVAP can provide a safe and effective system for long-term intravenous treatment of patients with acute leukemia” Ke et al (2026).
Economic value of implantable ports for long-term chemotherapy – Full Text

“Findings support the clinical and economic value of PORTs for long-term chemotherapy, difficult venous access, and low-maintenance needs, whereas PICCs suit shorter treatment durations, patients unsuitable for minor surgery, or settings favoring bedside insertion” Rognoni et al (2026).
CT guided implantation of totally implantable venous access port – full Text

“Totally implantable venous access ports (TIVAPs) have been proven to be safe and effective and are commonly used in cancer patients. Here, we introduce the entire procedure of CT-guided implantation of a TIVAP through the subclavian vein” Chen et al (2026).